EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities

Alexander V Beribisky, Anna Huber iD, Victoria Sarne iD, Andreas Spittler, Nyamdelger Sukhbaatar, Teresa Seipel, Franco Laccone, Hannes Steinkellner iD

Protein Science · 2024

DOI: 10.1002/pro.5170 ↗

At a glance

Journal article in Protein Science, 2024. Written by Alexander V Beribisky and 7 co-authors. Institution: Institute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria. Major MEDLINE topics: Methyl-CpG-Binding Protein 2, Cell Membrane, Histone Deacetylases. Cited 4 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY 4.0). Funded by: Italian Rett Syndrome Association.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The intrinsically disordered protein MeCP2 is a global transcriptional regulator encoded by the MECP2 gene. Although the structured domains of MeCP2 have been the subject of multiple studies, its unstructured regions have not been that extensively characterized. In this work, we show that MeCP2 possesses properties akin to those of supercharged proteins. By utilizing its unstructured portions, MeCP2 can successfully transduce across cell membranes and localize to heterochromatic foci in the nuclei, displaying uptake levels a third lower than a MeCP2 construct fused to the cell‐penetrating peptide TAT. MeCP2 uptake can further be enhanced by the addition of compounds that promote endosomal escape following cellular trafficking by means of macropinocytosis. Using a combination of in silico prediction algorithms and live‐cell imaging experiments, we mapped the sequence in MeCP2 responsible for its cellular incorporation, which bears a striking resemblance to TAT itself. Transduced MeCP2 was shown to interact with HDAC3. These findings provide valuable insight into the properties of MeCP2 and may be beneficial for devising future protein‐based treatment strategies.

Subjects

MeSH terms (MEDLINE)

Methyl-CpG-Binding Protein 2Cell MembraneHistone DeacetylasesHumansHEK293 CellsProtein TransportCell-Penetrating PeptidesHistone Deacetylase 3

Author keywords

MeCP2TAT fusion proteinscell penetrating peptidessupercharged protein

Substances

Methyl-CpG-Binding Protein 2Histone DeacetylasesCell-Penetrating PeptidesHistone Deacetylase 3MECP2 protein, human

Authors and institutions

  • Institute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
  • Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences (PhaNuSpo), University of Vienna, Vienna, Austria.
  • Core Facility Flow Cytometry & Department of Surgery, Research Laboratories, Vienna, Austria.

ORCID profiles: Anna Huber, Victoria Sarne, Hannes Steinkellner

Funding

  • Italian Rett Syndrome Association

Cite

APA

Beribisky, A. V., Huber, A., Sarne, V., Spittler, A., Sukhbaatar, N., Seipel, T., Laccone, F., & Steinkellner, H. (2024). MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities. Protein Science. https://doi.org/10.1002/pro.5170

Vancouver

Beribisky AV, Huber A, Sarne V, Spittler A, Sukhbaatar N, Seipel T, et al. MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities. Protein Science. 2024. doi:10.1002/pro.5170

BibTeX
@article{Beribisky2024,
  author = {Beribisky, Alexander V and Huber, Anna and Sarne, Victoria and Spittler, Andreas and Sukhbaatar, Nyamdelger and Seipel, Teresa and Laccone, Franco and Steinkellner, Hannes},
  title = {MeCP2 is a naturally supercharged protein with cell membrane transduction capabilities},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.5170}
}
Start for free →